Marimed (MRMD) Change in Receivables (2014 - 2026)
Marimed (MRMD) posted quarterly Change in Receivables of $401000.0 for Q1 2026, up 32.34% year-over-year from $303000.0 in Q1 2025, and down 71.4% quarter-over-quarter from $1.4 million in Q4 2025.
Marimed (MRMD) Change in Receivables (2014 - 2026) Analysis & Trends
Marimed (MRMD) has reported Change in Receivables for 13 consecutive years, with $401000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Change in Receivables rose 32.34% year-over-year to $401000.0; the TTM figure through Mar 2026 stood at $527000.0 (down 76.23% YoY), while the FY2025 annual figure was $429000.0, down 64.46% from the prior year.
- Change in Receivables fell to $401000.0 in Q1 2026 per MRMD's latest filing, from $1.4 million in the prior quarter.
- Across five years, Change in Receivables topped out at $2.0 million in Q4 2022 and bottomed at -$1.6 million in Q2 2025.
- Historically, Change in Receivables has averaged $711705.9 across 5 years, with a median of $1.1 million in 2023.
- Annual changes were most pronounced in 2024 — Change in Receivables sank 635.61% — and 2025, when it soared 160.85%.
- Marimed's Change in Receivables stood at $2.0 million in 2022, then tumbled by 46.48% to $1.1 million in 2023, then climbed by 11.05% to $1.2 million in 2024, then climbed by 15.3% to $1.4 million in 2025, then sank by 71.4% to $401000.0 in 2026.
- Business Quant data shows MRMD's Change in Receivables at $401000.0 in Q1 2026, $1.4 million in Q4 2025, and $328000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Receivables (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.85 Bn | 42.88 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 43.02 Bn | 39.37 Bn | 2.15 Bn | 91.00 Mn |
| 3 | Zoetis | 31.47 Bn | 29.79 Bn | 1.05 Bn | 66.00 Mn |
| 4 | Takeda Pharmaceutical | 28.59 Bn | 22.79 Bn | 5.10 Bn | -445.26 Mn |
| 5 | United Therapeutics | 22.20 Bn | 19.53 Bn | 683.80 Mn | -1.70 Mn |
| 6 | Viatris | 18.76 Bn | 17.87 Bn | 1.46 Bn | 126.50 Mn |
| 7 | Neurocrine Biosciences | 15.45 Bn | 15.06 Bn | 935.80 Mn | 84.30 Mn |
| 8 | Elanco Animal Health | 11.76 Bn | 11.23 Bn | 798.00 Mn | - |
| 9 | Dr Reddys Laboratories | 10.10 Bn | 9.94 Bn | - | - |
| 10 | Marimed | 30.77 Mn | 22.33 Mn | 16.23 Mn | 629,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 629,000.00 |
| Jun 30, 2026 | 629,000.00 |
| Mar 31, 2026 | 401,000.00 |
| Mar 31, 2026 | 401,000.00 |
| Dec 31, 2025 | 1.40 Mn |
| Dec 31, 2025 | 1.40 Mn |
| Sep 30, 2025 | 328,000.00 |
| Sep 30, 2025 | 328,000.00 |
| Jun 30, 2025 | -1.60 Mn |
| Jun 30, 2025 | -1.60 Mn |
| Mar 31, 2025 | 303,000.00 |
| Mar 31, 2025 | 303,000.00 |
| Dec 31, 2024 | 1.22 Mn |
| Dec 31, 2024 | 1.22 Mn |
| Sep 30, 2024 | -539,000.00 |
| Sep 30, 2024 | -539,000.00 |
| Jun 30, 2024 | 1.24 Mn |
| Jun 30, 2024 | 1.24 Mn |
| Mar 31, 2024 | -707,000.00 |
| Mar 31, 2024 | -707,000.00 |